Literature DB >> 7003385

Drug therapy: spasticity (second of two parts).

R R Young, P J Delwaide.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7003385     DOI: 10.1056/NEJM198101083040207

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  The effects of baclofen on calcium channel currents in dorsal sensory cells of the spinal cord in the lamprey.

Authors:  I V Batueva; J T Buchanan; E A Tsvetkov; A K Sagatelyan; N P Veselkin
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

Review 2.  Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.

Authors:  Alexander G Rabchevsky; Patrick H Kitzman
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Psoas compartment block for the treatment of lower-limb spasticity caused by spinal cord injury: report of a case.

Authors:  Motoyasu Takenaka; Hiroki Iida; Shuichiro Ohta; Shuji Dohi
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

4.  Variation in behavioral response to baclofen: correlation with benzodiazepine binding sites in mouse forebrain.

Authors:  L Rägo; R A Kiivet; J Harro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  Managing disability from stroke.

Authors:  J C Clifford
Journal:  Can Fam Physician       Date:  1986-03       Impact factor: 3.275

6.  Haemodialysis clearance of baclofen.

Authors:  Miran Brvar; Matjaz Vrtovec; Damjan Kovac; Gordana Kozelj; Tomaz Pezdir; Matjaz Bunc
Journal:  Eur J Clin Pharmacol       Date:  2007-09-02       Impact factor: 2.953

Review 7.  Intrathecal pumps.

Authors:  Shawn Belverud; Alon Mogilner; Michael Schulder
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  Pharmacokinetics of baclofen in spastic patients receiving multiple oral doses.

Authors:  E W Wuis; M J Dirks; T B Vree; E Van der Kleijn
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

9.  MDL 27,531 selectively reverses strychnine-induced seizures in mice.

Authors:  J H Kehne; J M Kane; F P Miller; H J Ketteler; D L Braun; Y Senyah; S F Chaney; A Abdallah; M W Dudley; A M Ogden
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

10.  Phosphinic acid derivatives as baclofen agonists and antagonists in the mammalian spinal cord: an in vivo study.

Authors:  G Lacey; D R Curtis
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.